Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production - PubMed (original) (raw)

Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production

T C van der Pouw Kraan et al. J Exp Med. 1995.

Abstract

During human immunodeficiency virus infection and allergic diseases, characterized by a dominant T helper (Th) 2 response, overproduction of prostaglandin E2 (PGE2) is observed. In this paper we studied the effect of PGE2 on interleukin (IL)-12 synthesis, because this cytokine has been described to be essential in induction of Th1 responses. IL-12 synthesis was induced in monocytes that were stimulated with Neisseria meningitidis-derived lipopolysaccharide in whole blood cultures. PGE2 almost completely inhibited lipopolysaccharide induced IL-12 production, whereas IL-6 production was only partially inhibited by PGE2. In contrast, the production of IL-10 was approximately twofold enhanced at these conditions. The effects of PGE2 were due to its cAMP-inducing capacity, since they could be mimicked by other cAMP inducers. Recombinant human IL-10 also inhibited IL-12 and IL-6 production. However, the inhibitory effect of PGE2 on IL-12 production was independent of IL-10 since neutralizing anti-IL-10 antibodies were unable to reverse this inhibition. These results suggest that the capacity of an antigen to induce PGE2 synthesis may play a crucial role in the development of either a Th1 or Th2 response.

PubMed Disclaimer

Similar articles

• Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production.
  Rieser C, Böck G, Klocker H, Bartsch G, Thurnher M. Rieser C, et al. J Exp Med. 1997 Nov 3;186(9):1603-8. doi: 10.1084/jem.186.9.1603. J Exp Med. 1997. PMID: 9348319 Free PMC article.
• Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12.
  Snijders A, Van der Pouw Kraan TC, Engel M, Wormmeester J, Widjaja P, Zonneveld IM, Bos JD, Kapsenberg ML. Snijders A, et al. Clin Exp Immunol. 1998 Mar;111(3):472-6. doi: 10.1046/j.1365-2249.1998.00516.x. Clin Exp Immunol. 1998. PMID: 9528885 Free PMC article.
• Blocking prostanoid receptors switches on multiple immune responses and cascades of inflammatory signaling against larval stages in snail fever.
  Saber S, Alomar SY, Yahya G. Saber S, et al. Environ Sci Pollut Res Int. 2022 Jun;29(29):43546-43555. doi: 10.1007/s11356-022-20108-1. Epub 2022 Apr 9. Environ Sci Pollut Res Int. 2022. PMID: 35396684 Free PMC article. Review.
• Production of interleukin-12.
  Ma X, D'Andrea A, Kubin M, Aste-Amezaga M, Sartori A, Monteiro J, Showe L, Wysocka M, Trinchieri G. Ma X, et al. Res Immunol. 1995 Sep-Oct;146(7-8):432-8. doi: 10.1016/0923-2494(96)83012-4. Res Immunol. 1995. PMID: 8839142 Review. No abstract available.

Cited by

• Mast cell-mediated immune regulation in health and disease.
  Dileepan KN, Raveendran VV, Sharma R, Abraham H, Barua R, Singh V, Sharma R, Sharma M. Dileepan KN, et al. Front Med (Lausanne). 2023 Aug 17;10:1213320. doi: 10.3389/fmed.2023.1213320. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37663654 Free PMC article. Review.
• Harnessing prostaglandin E2 signaling to ameliorate autoimmunity.
  Burkett JB, Doran AC, Gannon M. Burkett JB, et al. Trends Immunol. 2023 Mar;44(3):162-171. doi: 10.1016/j.it.2023.01.004. Epub 2023 Jan 25. Trends Immunol. 2023. PMID: 36707339 Free PMC article. Review.
• Utilizing mast cells in a positive manner to overcome inflammatory and allergic diseases.
  Zhang Z, Ernst PB, Kiyono H, Kurashima Y. Zhang Z, et al. Front Immunol. 2022 Sep 14;13:937120. doi: 10.3389/fimmu.2022.937120. eCollection 2022. Front Immunol. 2022. PMID: 36189267 Free PMC article. Review.
• Utilising Network Pharmacology to Explore Underlying Mechanism of Astragalus membranaceus in Improving Sepsis-Induced Inflammatory Response by Regulating the Balance of I_κ_B_α_ and NF-_κ_B in Rats.
  Yu H, Ling Q, Cai J, Zhang M, Liu H, Chen Y. Yu H, et al. Evid Based Complement Alternat Med. 2022 Mar 31;2022:7141767. doi: 10.1155/2022/7141767. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35399630 Free PMC article.
• Involvement of the Innate Immune System in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
  Kotlyarov S. Kotlyarov S. Int J Mol Sci. 2022 Jan 17;23(2):985. doi: 10.3390/ijms23020985. Int J Mol Sci. 2022. PMID: 35055174 Free PMC article. Review.

References

1. 1. J Immunol. 1991 May 1;146(9):3074-81 - PubMed
2. 1. J Immunol. 1991 Jan 1;146(1):108-13 - PubMed
3. 1. Immunol Today. 1991 Aug;12(8):256-7 - PubMed
4. 1. Immunol Today. 1991 Oct;12(10):349-52 - PubMed
5. 1. Immunology. 1992 Mar;75(3):391-7 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations